PeopleBio (304840.KQ) shares plummeted after the company announced the withdrawal of a third-party private placement.
PeopleBio closed at 960 won on the KOSDAQ market on January 22, down 355 won or 27% from the previous day. The direct cause of the share price drop was the collapse of a third-party private placement worth approximately 9 billion won ($6.6 million).
PeopleBio disclosed on January 19 that it had withdrawn the share issuance. Eastern Networks, the original subscriber of the new shares, failed to make payment on the due date, resulting in the cancellation of the new share issuance. Consequently, the management control transfer agreement was also terminated.
This issue is not directly related to clinical trials or business operations. However, the failed capital raise, which was intended to secure operating funds, has renewed uncertainty over short-term financing. Combined with the disappearance of expectations for a change in management control, this has increased stock price volatility, analysts say.
